Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients
MEDLINE; 2020.
Non-conventional
in English
| MEDLINE | ID: grc-750394
ABSTRACT
There are currently limited data on the epidemiology, clinical manifestations, and optimal management of Coronavirus Disease 2019 (COVID-19) in hematopoietic cell transplantation and cellular therapy recipients. Given the experience with other respiratory viruses, we anticipate that patients may develop severe clinical disease and thus provide the following general principles for cancer centers across the nation. These guidelines were developed by members of the American Society for Transplantation and Cellular Therapy Infectious Diseases Special Interest Group. Specific practices may vary depending on local epidemiology and testing capacity, and the guidance provided in this document may change as new information becomes available.
Full text:
Available
Collection:
Databases of international organizations
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Year:
2020
Document Type:
Non-conventional
Similar
MEDLINE
...
LILACS
LIS